U.S. ANIMAL HEALTH ASSN, VET LABORATORY DIAGNOSTICIANS TO HOLD JOINT MEETING
Aug. 6, 2013
Source: United States Animal Health Association and American Association of Veterinary Laboratory Diagnosticians joint news release
The United States Animal Health Association (USAHA) and American Association of Veterinary Laboratory Diagnosticians (AAVLD) have plans well underway for the 2013 joint Annual Meeting, scheduled for October 17-23, 2013 in San Diego, Calif.
This year's joint plenary session on Monday, October 21 will feature, "Vaccines: 100 years of Virus Serum Toxin Act and Beyond," providing a historical look at the Virus Serum Toxin Act (VSTA) over the years, including key disease impacts and economics as well as addressing current vaccine technology and future innovations.
"The 2013 USAHA/AAVLD Joint Plenary Session will provide a very comprehensive look at vaccines," says Dr. Catherine Barr, AAVLD Program Chair and Incoming President of AAVLD. "As our food supply and food safety systems become more and more reliant on disease resistance and prevention, understanding vaccine technology and regulatory programs past and present will be crucial."
Dr. Barr co-chairs the program with Dr. Steve Crawford, USAHA Program Chair and New Hampshire State Veterinarian. The two collaborated with colleagues, both in the U.S. and internationally in development of the program. They have tapped Dr. Ron DeHaven, AVMA Executive Vice President to moderate the session, which includes the following presentations:
Hog cholera: the need for VSTA
- Dr. Rick Hill, USDA-APHIS-VS
- Key concepts: history lesson, challenges, implementation.
The economics of vaccination: why do we vaccinate?
- Dr.John Hardham, Zoetis, on behalf of International Federation of Animal Health
- Key concepts: disease control, eradication, vaccine development considerations, vaccine deployment and administration considerations, as an alternative to depopulation.
Current technologies in vaccines
- Dr. Bryan Charleston, Pirbright or Dr. Dave Stuart, Oxford
- Key concepts: use FMD vaccine development as example; DIVA technology; speeding up the process; future technologies; public-private collaborations; the use of genome sequencing.
Autogenous vaccines: isn't this why VSTA was established?
- Dr. John A. Smith, Fieldale Farms
- Key concepts: risk/benefit, approval process, development needs, quality control and organism isolation.
Gap analysis for high consequence diseases
- Dr. Luis Rodriguez, USDA-ARS
- Key concepts: all with a focus on vaccines ~ African Swine Fever analysis conducted by ARS; current state, new spread, global implications, technology needs and advances.
Future of vaccines: beyond existing regulatory diseases
- Dr. Cyril Gay, USDA-ARS
- Key concepts: potential orbivirus gap analysis underway at ARS; possible involvement of regulatory medicine in the future of disease control beyond our current roles; what is the next frontier and/or how do we identify it?
In addition to the joint plenary session, AAVLD hosts a separate plenary session as well as numerous scientific sessions and committee meetings on a broad range of animal health diagnostic topics.
The AAVLD Plenary Session, entitled "Getting Ahead of the Ball: Diagnostic Adaptation in a Global Health Community" will delve into diagnostic and epidemiologic strategies brought to bear to combat recently emerging disease outbreaks (EHV-1, PEDV, H7N9), lessons learned, and opportunities for future responses.
The AAVLD poster displays will offer insight into some of the latest research being conducted.
Learn more about the entire list of events at
www.aavld.org/annual-meeting-2013. Registration is now available for interested attendees - take advantage of early-bird registration and membership discounts.